Stockchase Opinions

Charles Lannon Reckitt Benckiser RBGLY-OTC DON'T BUY Jun 24, 2015

Makes everything from over-the-counter birth-control products to food sauces. This has probably been the most popular European consumer staples stock. Very respected management team. Unfortunately most of that has been caught up in the price. Wouldn’t recommend at these price levels.

$0.010

Stock price when the opinion was issued

misc consumer products
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

BUY
Reckitt's CEO says that hygiene is the strongest theme in this industry now and will endure. Habits will stick beyond the pandemic. Investments to expand the company are now paying off.
premium

It's a Monthly Gems opinion which is available only for Premium members

Curated by Allan Tong since 2019.
99+ opinions with 4.15 rating.

TOP PICK
Another consideration is Benckiser (RBGLY:OTC) which owns a wide portfolio of consumer products (e.g. facial washes, heartburn meds, condoms, cleansing pads, sore throat solutions). These are products that consumers will buy even in a recession, which makes RB defensive. Another plus is that RB products are sold in more than 200 countries with the U.K. totaling only 8% of revenues (from 2018). So, if British consumers do tighten their wallets if there's no trade deal, then RB is largely protected from that hit. Also, RB pays a decent yield of 2.32%, but boasts 16 straight dividend increases. That said, RB suffered a “modest decline” in operating margins last October when it guided down, but the new CEO plans to unveil a new plan this month when the company reports annual results. Again, RB isn't a screaming buy, but it's a fairly safe, long-term bet.
TOP PICK
Hygiene products, lozenges, baby formula. Global. Suffered with management missteps, but has cleaned house. New team has increased revenues and profit margins. Getting better penetration in other markets and geographies. Going to see good earnings growth and rising dividend. Cheap. Yield is 2.80%. (Target price is in pounds.) (Analysts’ price target is $7088.50)
PAST TOP PICK
(A Top Pick Nov 11/21, Up 9%) Has done well along with other consumer staples. Back on track, growth has come back from depressed levels. Growth in high single digits. Investing in brands they already own.
PAST TOP PICK
(A Top Pick Nov 11/21, Down 5%) Consumer products company (Lysol etc.) Difficult times, but undergoing turnaround. Revenue growth estimated to be ~8%. Will continue to hold.
TOP PICK
price target 7,153.68 GBP Like a mini Unilever in packaged goods. They make Lysol, for example. They made a bad purchase in 2019 of a baby food company that had distribution problems. That pressured the stock, but is now behind them. Revenues are growing near 10%, operating margins are up 3% and free cash is up 4% in the last year. They have a portfolio of brands that will do well. Highly defensive.
TOP PICK
It also trades under the symbol RKT-LON. Lysol, very popular during the pandemic, is one of its major products, among others. It is undergoing a turnaround and is very well run, trading at a discount to other consumer products businesses, a good area to be in. Trades at 17X earnings with a 3% dividend and growing margins. It has unique products and could make some good niche acquisitions. Buy 16 Hold 5 Sell 0
PAST TOP PICK
(A Top Pick Nov 22/22, Up 5%)

Own this for defence. They've benefitted from inflation. Are getting into emerging markets which enjoy population growth, and in turn fuel company growth.

DON'T BUY

Many UK stocks have been hit by Brexit. The UK pound has been declining against the Canadian dollar. The company isn't doing well, either, though its valuation is cheap. Look elsewhere like P&G.

PAST TOP PICK
(A Top Pick Jan 23/23, Down 16%)

He recently sold. Sadly, baby died from its high-risk infant formula. $60M judgement. Billions more in lawsuits just waiting in the wings. Asked himself if he'd buy today if not already owned, the answer was no, so he sold.